{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidl7aiwffgdtxxrrufeujxoud2fk4tgud2svu264i65xxco4pspku",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mlw3t6xjy2h2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiaxt6b5r5o4ixakft6iz43vzvrktd7ghd6z6f6ejruq5t6zjpwyzu"
    },
    "mimeType": "image/jpeg",
    "size": 631756
  },
  "path": "/news/2026-05-antiviral-ensitrelvir-covid-household-contacts.html",
  "publishedAt": "2026-05-15T15:00:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "The antiviral drug ensitrelvir prevents infection in household contacts of COVID-19 patients when given within 72 hours after symptom onset in the index patient, according to a Phase III randomized controlled trial published in the New England Journal of Medicine.",
  "title": "Antiviral ensitrelvir cuts risk of COVID-19 in household contacts by two-thirds, study finds"
}